PRESCRIBING · PART D · 2024
Total Rx claims
814
Beneficiaries
—
Total drug cost
$132K
Distinct drugs
14
Brand share
5.9%
Top prescribed drugs
Fluticasone Propionate213 claims
Famotidine209 claims
Pantoprazole Sodium120 claims
Montelukast Sodium56 claims
Levocetirizine Dihydrochloride41 claims
QUALITY · MIPS · 2024
Final MIPS score
89.6
Quality
24.9
Cost
65.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.61%
Group
CROSS-REFERENCE